Total synthesis and assignment of configuration of lissoclinamide 7

Journal of the American Chemical Society

Volumn 118, Issue 49, 1996, Pages 12358-12367

  Wipf, Peter ^a   Fritch, Paul C ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPEPTIDE; CYTOTOXIC AGENT; LISSOCLINAMIDE 7; UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; TECHNIQUE;

EID: 0030458540     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja962859f     Document Type: Article

References (62)

1. Wipf, P.; Miller, C. P. J. Am. Chem. Soc. 1992, 114, 10975.
2. (a) Wipf, P.; Xu, W. J. Org. Chem. 1996, 61, 6556.
3. (b) Wipf, P.; Venkatraman, S. J. Org. Chem. 1996, 61, 6517.
4. Wipf, P.; Lim, S. J. Am. Chem. Soc. 1995, 117, 558.
5. Wipf, P.; Kim, H. Y. J. Org. Chem. 1993, 58, 5592.
6. For a recent review of metabolites of ascidians, see: Davidson, B. S. Chem. Rev. 1993, 93, 1771.
7. Recently, structurally closely related compounds have also been isolated from other ascidians, sea hares, and cyanobacteria. (a) Dolastatin E (from Dolabella auricularia): Ojika, M.; Nemoto, T.; Nakamura, M.; Yamada, K. Tetrahedron Lett. 1995,36,5057.
8. (b) Cyclodidemnamide (from Didemnum molle): Toske, S. G.; Fenical, W. Tetrahedron Lett. 1995, 36, 8355.
9. Nostocyclamide (from Nostoc sp. 31): Todorova, A. K.; Jüttner, F.; Linden, A.; Plüss, T.; von Philipsborn, W. J. Org. Chem. 1995, 60, 7891.
10. Westiellamide (cycloxazoline) was also isolated from the terrestrial cyanophyte Westiellopsis prolifica: Prinsep, M. R.; Moore, R. E.; Levine, I. A.; Patterson, G. M. L. J. Nat. Prod. 1992, 55, 140.
11. (a) Ishida, T.; Inoue, M.; Hamada, Y.; Kalo, S.; Shioiri, T. J. Chem. Soc., Chem. Commun. 1987, 370.
12. (b) Ishida, T.; Tanaka, M.; Nabae, M.; Inoue, M; Kato, S.; Hamada, Y.; Shioiri, T. J. Org. Chem. 1988, 53, 107.
13. Schmitz, F. J.; Ksebati, M. B.; Chang, J. S.; Wang, J. L.; Hossain, M. B.; Helm, D. v. d.; Engel, M. H.; Serban, A.; Silfer, J. A. J. Org. Chem. 1989, 54, 3463.
14. Ishida, T.; Ohishi, H.; Inoue, M.; Kamigauchi, M.; Sugiura, M.; Takao, N.; Kato, S.; Hamada, Y.; Shioiri, T. J. Org. Chem. 1989, 54, 5337.
15. (e) Hambley, T. W.; Hawkins, C. J.; Lavin, M. F.; Brenk, A. v. d.; Watters, D. J. Tetrahedron 1992, 48, 341.
16. (f) Ishida, T.; In, Y.; Doi, M.; Inoue, M.; Hamada, Y.; Shioiri, T. Kopolymers 1992, 32, 131.
17. (g) McDonald, L. A.; Foster, M. P.; Phillips, D. R.; Ireland, C. M.; Lee, A. Y.; Clardy, J. J. Org. Chem. 1992, 57, 4616.
18. (h) In, Y.; Doi, M.; Inoue, M.; Ishida, T.; Hamada, Y.; Shioiri, T. Chem. Pharm. Bull. 1993,41, 1686.
19. In, Y.; Doi, M.; Inoue, M.; Ishida, T.; Hamada, Y.; Shioiri, T. Acta Crystallogr. 1994, C50, 432.
20. (j) Ishida, T.; In, Y.; Shinozaki, F.; Doi, M.; Yamamoto, D.; Hamada, Y.; Shioiri, T.; Kamigauchi, M.; Sugiura, M. J. Org. Chem. 1995, 60, 3944.
21. For a review, see: Sessler, J. L.; Burrell, A. K. Top. Curr. Chem. 1991, 161, 177.
22. Bradshaw, J. S.; Krakowiak, K. E.; Izatt, R. M. In Aza-crawn Macrocycles; Wiley: New York, 1993.
23. Michael, J. P.; Pattenden, G. Angew. Chem., Int. Ed. Engl. 1993,32, 1.
24. Wipf, P.; Venkatraman, S.; Miller, C. P.; Geib, S. J. Angew. Chem.. Int. Ed. Engl. 1994, 33, 1516.
25. (a) Brenk, A. L. v. d.; Byriel, K. A.; Fairlie, D. P.; Gahan, L. R.; Hanson, G. R.; Hawkins, C. J.; Jones, A.; Kennard, C. H. L.; Moubaraki, B.; Murray, K. S. Inorg. Chem. 1994, 33, 3549.
26. (b) Brenk, A. L. v. d.; Fairlie, D. P.; Hanson, G. R.; Gahan, L. R.; Hawkins, C. J.; Jones, A. Inorg. Chem. 1994, 33, 2280.
27. (a) Shioiri, T.; Hamada, Y.; Kato, S.; Shibata, M.; Kondo, Y.; Nakagawa, H.; Kohda, K. Biochem. Pharm. 1987, 36, 4181.
28. (b) Kohda, K.; Ohta, Y.; Kawazoe, Y.; Kato, T.; Suzumura, Y.; Hamada, Y.; Shioiri, T. Biochem. Pharm. 1989, 38, 4500.
29. Kohda, K.; Ohta, Y.; Yokoyama, Y.; Kawazoe, Y.; Kato, T.; Suzumura, Y.; Hamada, Y.; Shioiri, T. Biochem. Pharm. 1989, 38, 4497.
30. Wipf, P.; Venkatraman, S. Synlett In press.
31. For a review, see: Wipf, P. Chem. Rev. 1995, 95, 2115.
32. Ascidiacyclamide (2 oxazolines, 2 thiazoles): Hamada, Y.; Kato, S.; Shioiri, T. Tetrahedron Lett. 1985,16, 3223.
33. Bistratamide C (1 oxazole, 2 thiazoles): Aguilar, E.; Meyers, A. I. Tetrahedron Lett. 1994, 35, 2477.
34. Dolastatin 3 (2 thiazoles): Pettit, G. R.; Kamano, Y.; Holzapfel, C. W.; van Zyl, W. J.; Tuinman, A. A.; Herald, C. L.; Baczynskyj, L.; Schmidt, J. M. J. Am. Chem. Sue. 1987,109,7581.
35. Schmidt, U.; Utz, R.; Lieberknecht, A.; Griesser, H.; Potzolli, B.; Bahr, J.; Wagner, K.; Fischer, P. Synthesis 1987, 236.
36. Lissoclinamide 5 (1 oxazoline, 2 thiazoles): Boden, C.; Pattenden, G. Tetrahedron Lett. 1994,35, 8271.
37. Patellamides A, B, and C (2 oxazolines, 2 thiazoles): Hamada, Y.; Shibata, M.; Shioiri, T. Tetrahedron Lett. 1985, 26, 5159.
38. Hamada, Y.; Shibata, M.; Shioiri, T. Tetrahedron Lett. 1985, 26, 6501.
39. Schmidt, U.; Griesser, H. Tetrahdron Lett. 1986, 27, 163.
40. Ulicyclamide (1 oxazoline, 2 thiazoles): Schmidt, U.; Gleich, P. Angew. Chem., Int. Ed. Engl. 1985, 24, 569.
41. Sugiura, T.; Hamada, Y.; Shioiri, T. Tetrahedron Lett. 1987, 28, 2251.
42. Ulithiacyclamide (2 oxazolines, 2 thiazoles): Kato, S.; Hamda, Y.; Shioiri, T. Tetrahedron Lett. 1986, 27, 2653.
43. Schmidt, U.; Weller, D. Tetrahedron Lett. 1986, 27, 3495. Westiellamide (3 oxazolines): ref 1.
44. Boden, C. D. J.; Pattenden, G. Tetrahedron Lett. 1995, 36, 6153.
45. Nakamura, M.; Shibata, T.; Nakane, K.; Nemoto, T.; Ojika, M.; Yamada, K. Tetrahedron Lett. 1995, 36, 5059.
46. Wipf, P.; Fritch, P. C. Tetrahedron Lett. 1994, 35, 5397.
47. Boden, C. D. J.; Pattenden, G.; Ye, T. Synlett 1995, 417.
48. Wasylyk, J. M.; Biskupiak, J. E; Costello, C. E.; Ireland, C. M. J. Org. Chem. 1983, 48, 4445. This activity was determined in L1210 cells.
49. (a) Hawkins, C. J.; Lavin, M. F.; Marshall, K. A.; Brenk, A. L. v. d.; Watters, D. J. J. Med. Chem. 1990, 33, 1634.
50. (b) Degnan, B. M.; Hawkins, C. J.; Lavin, M. F.; McCaffrey, E. J.; Parry, D. L.; Brenk, A. L. v. d.; Watters, D. J. J. Med. Chem. 1989, 32, 1349. This activity was determined in T24 cells.
51. Ireland, C. M.; Durso, A. R.; Newman, R. A.; Hacker, M. P. J. Org. Chem. 1982, 47, 1807. This activity was determined in L1210 cells.
52. Wipf, P.; Miller, C. P. J. Org. Chem. 1993, 58, 1575.
53. (a) Chen, S.; Xu, J. Tetrahedron Lett. 1991, 32, 6711.
54. (b) Dudash, J.; Jiang, J.; Mayer, S. C.; Joullie, M. M. Synth. Commun. 1993, 23, 349.
55. (a) Wipf, P.; Miller, C. P. Tetrahedron Lett. 1992, 33, 6267.
56. (b) Galeotti, N.; Montagne, C.; Poncet, J.; Jouin, P. Tetrahedron Lett. 1992, 33, 2807.
57. 13C NMR spectra of natural lissoclinamide 7. We thank Prof. D. Walters for providing us with copies of her data.
58. For an example of the simultaneous formation of an oxazoline and a thiazoline using this methodology, see: Boden and Pattenden (ref 18). In the cyclopeptide area, the simultaneous formation of two oxazolines was reported by Shioiri et al. and Schmidt et al. (refs 13 and 14). For the simultaneous formation of multiple thiazolines or oxazolines in linear polyazoles, see: Parsons, R. L.; Heathcock, C. H. Tetrahedron Lett. 1994, 35, 1383.
59. Parsons, R. L.; Heathcock, C. H. J. Org. Chem. 1994, 59, 4733.
60. Wipf, P.; Venkatraman, S. J. Org. Chem. 1995, 60, 7224.
61. For comparison, see: Boger, D. L.; Zhou, J. J. Org. Chem. 1996, 61, 3938 and references cited therein.
62. The coordinates and a detailed discussion of the three-dimensional structure of lissoclinamide 7 will be reported elsewhere.